EUVIMEDEUVIMED entdecken
Crossref

Outcomes With Femoral IABP in Heart Failure and Acute Myocardial Infarction-Related Cardiogenic Shock

Arthur Reshad Garan, Arvind Bhimaraj, Rachna Kataria, Aniket Rali, E Wilson Grandin, Alvaro A Delgado, Ajar Kochar, Borui Li, Manreet K Kanwar, Shashank S Sinha, Jaime Hernandez-Montfort, Jacob Abraham und 34 weitere

Journal of Cardiac Failure · 2026

DOI: 10.1016/j.cardfail.2025.04.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiac Failure, 2026. Verfasst von Arthur Reshad Garan und 45 weiteren Autor:innen. Beteiligte Einrichtung: Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Intra-Aortic Balloon Pumping, Heart Failure, Myocardial Infarction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intra-aortic balloon pump (IABP) insertion has not been shown to improve mortality rates in acute myocardial infarction-related cardiogenic shock (AMI-CS) but is increasingly used in heart failure-related cardiogenic shock (HF-CS). OBJECTIVE: We sought to compare IABP-related outcomes in patients with HF-CS and AMI-CS. METHODS: The Cardiogenic Shock Working Group registry was queried for patients with CS receiving femoral IABPs as the first temporary mechanical circulatory support (tMCS) device. Patients were divided into those with AMI-CS or HF-CS and were excluded if they received the IABP in conjunction with venoarterial extracorporeal membrane oxygenation (VA-ECMO) or another device concomitantly. Outcomes, including rates of native heart survival (NHS) (ie, weaned from IABP and discharged), heart replacement therapy (HRT) (ie, bridge to durable left ventricular assist device or heart transplant), need for another tMCS device, and death, were recorded and compared between the 2 cohorts. RESULTS: In total, 886 patients were supported by IABPs as the first tMCS device; of these, 407 (45.6%) had HF-CS and 384 (43.3%) had AMI-CS. Those with HF-CS were younger but had higher burdens of cardiovascular comorbidities than those with AMI-CS. Among the HF-CS cohort, 33.2% had NHS, and 26.7% were bridged to HRT without another tMCS device. In the AMI-CS cohort, 43.4% had NHS and 2.1% were bridged to HRT without another tMCS device. Mortality rates were higher in AMI-CS group (36.4% vs 20.6%; P < 0.001). Complication rates were higher in those with AMI-CS and in those needing another tMCS device. CONCLUSION: Patients with HF-CS were more likely to have a favorable outcome with IABPs than those with AMI-CS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, CardiogenicIntra-Aortic Balloon PumpingHeart FailureMyocardial InfarctionHumansFemaleRegistriesMaleAgedTreatment OutcomeMiddle AgedFemoral ArteryRetrospective Studies

Stichwörter der Autor:innen

Cardiogenic shockIABPacute myocardial infarctionheart failurehemodynamics

Autor:innen und Institutionen

  • Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
  • Methodist DeBakey Cardiology Associates, Houston Methodist Hospital, Houston, TX.
  • Lifespan Cardiovascular Institute, Brown University, Providence, RI.
  • Vanderbilt University, Nashville, TN.
  • Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • The Cardiovascular Center, Tufts Medical Center, Boston, MA.

Zitieren

APA

Garan, A. R., Bhimaraj, A., Kataria, R., Rali, A., Grandin, E. W., Delgado, A. A., Kochar, A., Li, B., Kanwar, M. K., Sinha, S. S., Hernandez-Montfort, J., Abraham, J., Li, S., Arias-Mendoza, A., Bezerra, H., Blumer, V., Chiang, I. H., Farr, M. J., Fried, J., …, & Kapur, N. K. (2026). Outcomes With Femoral IABP in Heart Failure and Acute Myocardial Infarction-Related Cardiogenic Shock. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2025.04.007

Vancouver

Garan AR, Bhimaraj A, Kataria R, Rali A, Grandin EW, Delgado AA, et al. Outcomes With Femoral IABP in Heart Failure and Acute Myocardial Infarction-Related Cardiogenic Shock. Journal of Cardiac Failure. 2026. doi:10.1016/j.cardfail.2025.04.007

BibTeX
@article{Garan2026,
  author = {Garan, Arthur Reshad and Bhimaraj, Arvind and Kataria, Rachna and Rali, Aniket and Grandin, E Wilson and Delgado, Alvaro A and Kochar, Ajar and Li, Borui and Kanwar, Manreet K and Sinha, Shashank S and Hernandez-Montfort, Jaime and Abraham, Jacob and Li, Song and Arias-Mendoza, Alexandra and Bezerra, Hiram and Blumer, Vanessa and Chiang, I-Hui and Farr, Mary Jane and Fried, Justin and Gage, Ann and Hall, Shelley and Hickey, Gavin W and Ilonze, Onyedika and Guglin, Maya and Khalife, Wissam and Kim, J U and Lundgren, Scott and Marbach, Jeffrey and Mishkin, Joseph and Nathan, Sandeep and Pahuja, Mohit and Schwartzman, Andrew and Ton, VAN-Khue and Vishnevsky, Oleg Alec and Vorovich, Esther and Wald, Joyce and Zweck, Elric and Kong, Qiuyue and Sangal, Paavni and Walec, Karol D and Zazzali, Peter and Harwani, Neil M and John, Kevin and Mahr, Claudius and Burkhoff, Daniel and Kapur, Navin K},
  title = {Outcomes With Femoral IABP in Heart Failure and Acute Myocardial Infarction-Related Cardiogenic Shock},
  journal = {Journal of Cardiac Failure},
  year = {2026},
  doi = {10.1016/j.cardfail.2025.04.007}
}
Kostenlos starten →